Quality measures for acute kidney injury and continuous renal replacement therapy

Current Opinion in Critical Care

Volumn 21, Issue 6, 2015, Pages 490-499

  Rewa, Oleksa ^a   Mottes, Theresa ^b   Bagshaw, Sean M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Acute kidney injury; Continuous renal replacement therapy; Quality; Safety

Indexed keywords

HEPARIN; PROTAMINE;

ACUTE KIDNEY FAILURE; ANTICOAGULATION; CONTINUOUS RENAL REPLACEMENT THERAPY; COST EFFECTIVENESS ANALYSIS; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HIGH RISK PATIENT; HUMAN; PATIENT SAFETY; PRESCRIPTION; REVIEW; TOTAL QUALITY MANAGEMENT; ACUTE KIDNEY INJURY; CLINICAL PROTOCOL; CRITICAL ILLNESS; IN SERVICE TRAINING; ORGANIZATION AND MANAGEMENT; PHYSIOLOGIC MONITORING; PROCEDURES; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; STANDARDS; TIME FACTOR;

ACUTE KIDNEY INJURY; CLINICAL PROTOCOLS; CRITICAL ILLNESS; HUMANS; INSERVICE TRAINING; MONITORING, PHYSIOLOGIC; PATIENT SAFETY; QUALITY INDICATORS, HEALTH CARE; QUALITY OF HEALTH CARE; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; TIME FACTORS;

EID: 84947065977     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0000000000000262     Document Type: Review

References (73)

1. National Research Council. To err is human: building a safer health system. Washington, DC: The National Academies Press; 2000.
2. Institute of Medicine. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: The National Academies Press; 2001.
3. Ronco C, Kellum JA, Mehta R. Acute dialysis quality initiative (ADQI). Nephrol Dial Transplant 2001; 16:1555-1558.
4. Ronco C, Kellum JA, Bellomo R, Mehta RL. Acute dialysis quality initiative (ADQI). Contrib Nephrol 2013; 182:1-4.
5. Bellomo R, Ronco C, Kellum JA, et al. Acute dialysis quality initiative w. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8:R204-R212.
6. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of aninitiative to improve outcomes in acute kidney injury. Crit Care 2007; 11:R31.
7. Aitken E, Carruthers C, Gall L, et al. Acute kidney injury: outcomes and quality of care. QJM 2013; 106:323-332.
8. Wald R, McArthur E, Adhikari NK, et al. Changing incidence and outcomes following dialysis-requiring acute kidney injury among critically ill adults: a population-based cohort study. Am J Kidney Dis 2015; 65:870-877.
9. Allegretti AS, Steele DJ, David-Kasdan JA, et al. Continuous renal replace ment therapy outcomes in acute kidney injury and end-stage renal disease: a cohort study. Crit Care 2013; 17:R109.
10. Baker GR, Norton PG, Flintoft V, et al. The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada. CMAJ 2004; 170:1678-1686.
11. Stelfox HT, Palmisani S, Scurlock C, et al. The 'To Err is Human' report and the patient safety literature. Qual Saf Health Care 2006; 15:174-178.
12. Mansfield JG, Caplan RA, Campos JS, et al. Using a quantitative risk register to promote learning from a patient safety reporting system. Jt Comm J Qual Patient Saf 2015; 41:76-81.
13. McFadden KL, Stock GN, Gowen CR 3rd. Leadership, safety climate, and continuous quality improvement: impact on process quality and patient safety. J Nurs Adm 2014; 44 (10 Suppl):S27-S37.
14. National Institute for Health and Care Excellence. http://www.nice.org.uk/. [Accessed 19 September 2015]
15. Acute Dialysis Quality Initiative. 2015. http://www.adqi.org. [Accessed 19 September 2015]
16. Acute Kidney Injury Network. 2015. http://www.akinet.org. [Accessed 19 September 2015]
17. KDIGO-Acute Kidney Injury. 2015. http://kdigo.org/home/guidelines/acute-kidney-injury/.
18. Ronco C, Levin A, Warnock DG, et al. Improving outcomes from acute kidney injury (AKI): report on an initiative. Int J Artif Organs 2007; 30:373-376.
19. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Working Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012; 2:1-138.
20. James MT, Wald R, Bell CM, et al. Weekend hospital admission, acute kidney injury, and mortality. J Am Soc Nephrol 2010; 21:845-851.
21. Akhoundi A, Singh B, Vela M, et al. Incidence of adverse events during continuous renal replacement therapy. Blood Purif 2015; 39:333-339.
22. Stucker F, Ponte B, Tataw J, et al. Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial. Crit Care 2015; 19:91.
23. Zamperetti N, Ronco C, Brendolan A, et al. Bioethical issues related to continuous renal replacement therapy in intensive care patients. Intensive Care Med 2000; 26:407-415.
24. Smith OM, Wald R, Adhikari NK, et al. Standard versus accelerated initiation of renal replacement therapy in acute kidney injury (STARRT-AKI): study protocol for a randomized controlled trial. Trials 2013; 14:320.
25. Ethgen O, Schneider AG, Bagshaw SM, et al. Economics of dialysis dependence following renal replacement therapy for critically ill acute kidney injury patients. Nephrol Dial Transplant 2015; 30:54-61.
26. Srisawat N, Lawsin L, Uchino S, et al. Cost of acute renal replacement therapy in the intensive care unit: results from The Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) study. Crit Care 2010; 14:R46.
27. Wald R, Friedrich JO, Bagshaw SM, et al. Optimal mode of clearance in critically ill patients with Acute Kidney Injury (OMAKI)-a pilot randomized controlled trial of hemofiltration versus hemodialysis: a Canadian Critical Care Trials Group project. Crit Care 2012; 16:R205.
28. Bellomo R, Cass A, Cole L, et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 2009; 361:1627-1638.
29. Pavelsky PM, Zhang JH, O'Connor TZ, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008; 359:7-20.
30. Elseviers MM, Lins RL, Van der Niepen P, et al. Renal replacement therapy is an independent risk factor for mortality in critically ill patients with acute kidney injury. Crit Care 2010; 14:R221.
31. Stevens PE, Tamimi NA, Al-Hasani MK, et al. Nonspecialist management of acute renal failure. QJM 2001; 94:533-540.
32. Mehta RL, McDonald B, Gabbai F, et al. Nephrology consultation in acute renal failure: does timing matter? Am J Med 2002; 113:456-461.
33. Mottes T, Owens T, Niedner M, et al. Improving delivery of continuous renal replacement therapy: impact of a simulation-based educational intervention. Pediatr Crit Care Med 2013; 14:747-754.
34. Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygena-tion for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009; 374:1351-1363.
35. Kawai Y, Cornell TT, Cooley EG, et al. Therapeutic plasma exchange may improve hemodynamics and organ failure among children with sepsis-induced multiple organ dysfunction syndrome receiving extracorporeal life support. Pediatr Crit Care Med 2015; 16:366-374.
36. Chen H, Yu RG, Yin NN, Zhou JX. Combination of extracorporeal membrane oxygenation and continuous renal replacement therapy in critically ill patients: a systematic review. Crit Care 2014; 18:675.
37. Legrand M, Darmon M, Joannidis M, Payen D. Management of renal replace ment therapy in ICU patients: an international survey. Intensive Care Med 2013; 39:101-108.
38. Rosner MH, Ostermann M, Murugan R, et al. Indications and management of mechanical fluid removal in critical illness. Br J Anaesth 2014; 113:764-771.
39. Schetz M, Leblanc M, Murray PT. The Acute Dialysis Quality Initiative-part VII: fluid composition and management in CRRT. Adv Ren Replace Ther 2002; 9:282-289.
40. Bellomo R, Cole L, Reeves J, Silvester W. Who should manage CRRT in the ICU? The intensivist's viewpoint. Am J Kidney Dis 1997; 30 (5 Suppl 4): S109-S111.
41. Graham P, Lischer E. Nursing issues in renal replacement therapy: organization, manpower assessment, competency evaluation and quality improvement processes. Semin Dial 2011; 24:183-187.
42. Martin RK. Who should manage CRRT in the ICU? The nursing viewpoint. Am J Kidney Dis 1997; 30 ((5 Suppl 4)):S105-S108.
43. Kee YK, Kim EJ, Park KS, et al. The effect of specialized continuous renal replacement therapy team in acute kidney injury patients treatment. Yonsei Med J 2015; 56:658-665.
44. Oh HJ, Lee MJ, Kim CH, et al. The benefit of specialized team approaches in patients with acute kidney injury undergoing continuous renal replacement therapy: propensity score matched analysis. Crit Care 2014; 18:454.
45. Lyndon WD, Wille KM, Tolwani AJ. Solute clearance in CRRT: prescribed dose versus actual delivered dose. Nephrol Dial Transplant 2012; 27:952-956.
46. Uchino S, Fealy N, Baldwin I, et al. Continuous is not continuous: the incidence and impact of circuit 'down-time' on uraemic control during continuous veno-venous haemofiltration. Intensive Care Med 2003; 29:575-578.
47. Mencia S, Lopez M, Lopez-Herce J, et al. Simulating continuous renal replacement therapy: usefulness of a new simulator device. J Artif Organs 2014; 17:114-117.
48. Parienti JJ, Thirion M, Megarbane B, et al. Femoral vs jugular venous cathe-terization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA 2008; 299: 2413-2422.
49. Ge X, Cavallazzi R, Li C, et al. Central venous access sites for the prevention of venous thrombosis, stenosis and infection. Cochrane Database Syst Rev 2012; 3:CD004084.
50. Crosswell A, Brain MJ, Roodenburg O. Vascular access site influences circuit life in continuous renal replacement therapy. Crit Care Res 2014; 16:127-130.
51. Fernandez SN, Santiago MJ, Lopez-Herce J, et al. Citrate anticoagulation for CRRT in children: comparison with heparin. Biomed Res Int 2014; 786301.
52. Sheehan J, Ezra M. Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy 1A02, 3C00. JICS 2013; 14:84-85.
53. Wu MY, Hsu YH, Bai CH, et al. Regional citrate versus heparin anticoagula-tion for continuous renal replacement therapy: a meta-analysis of randomized controlled trials. Am J Kidney Dis 2012; 59:810-818.
54. Schilder L, Nurmohamed SA, Bosch FH, et al. Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multicenter randomized clinical trial. Crit Care 2014; 18:472-481.
55. Davis TK, Neumayr T, Geile K, et al. Citrate anticoagulation during continuous renal replacement therapy in pediatric critical care. Pediatr Crit Care Med 2014; 15:471-485.
56. Balogun RA, Turgut F, Caldwell S, Abdel-Rahman EM. Regional citrate anticoagulation in critically ill patients with liver and kidney failure. J Nephrol 2012; 25:113-119.
57. Chadha V, Garg U, Warady BA, Alon US. Citrate clearance in children receiving continuous venovenous renal replacement therapy. Pediatr Nephrol 2002; 17:819-824.
58. Wu MY, Hsu YH, Bai CH, et al. Regional citrate versus heparin anticoagula-tion for continuous renal replacement therapy: a meta-analysis of randomized controlled trials. Am J Kidney Dis 2012; 59:810-818.
59. Gattas DJ, Rajbhandari D, Bradford C, et al. A randomized controlled trial of regional citrate versus regional heparin anticoagulation for continuous renal replacement therapy in critically ill adults. Crit Care Med 2015; 43:1622-1629.
60. Gershengorn HB, Kocher R, Factor P. Management strategies to effect change in intensive care units: lessons from the world of business. Part II. Quality-improvement strategies. Ann Am Thorac Soc 2014; 11:444-453.
61. Byrne J, Xu G, Carr S. Developing an intervention to prevent acute kidney injury: using the Plan, Do, Study, Act (PDSA) service improvement approach. J Ren Care 2015; 41:3-8.
62. Wiseman B, Kaprielian V. QI: Patient safety-quality improvement. 2014; http://patientsafetyed.duhs.duke.edu/module-a/module-overview.html. [Accessed 19 September 2015]
63. Davis E. A quality improvement project in diabetes patient education during hospitalization. Diabetes Spectr 2000; 13:228-231.
64. National Quality Forum. http://www.qualityforum.org/Home.aspx.
65. Benfield CB, Brummond P, Lucarotti A, et al. Applying lean principles to continuous renal replacement therapy processes. Am J Health Syst Pharm 2015; 72:218-223.
66. Hlubocky J, Brummond P, Clark JS. Pharmacy practice model change: lean thinking provides a place to start. Am J Health Syst Pharm 2013; 70:845-847.
67. National Institute for Health and Clinical Excellence (NICE). Acute kidney injury: Prevention, detection and management of acute kidney injury up to the point of renal replacement therapy. 2013. http://www.nice.org.uk/guidance/cg169/resources/guidance-acute-kidney-injury-pdf. [Accessed 18 September 2015]
68. Kolhe NV, Staples D, Reilly T, et al. Impact of compliance with a care bundle on acute kidney injury outcomes: a prospective observational study. PLoS One 2015; 10:e0132279.
69. Cox ZL, McCoy AB, Matheny ME, et al. Adversedrug events during AKI and its recovery. Clin J Am Soc Nephrol 2013; 8:1070-1078.
70. Uchino S, Bellomo R, Morimatsu H, et al. Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med 2007; 33:1563-1570.
71. Hoste EA, Bagshaw SM, Bollomo R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 2015; 41:1411-1423.
72. Tolwani A. Continuous renal-replacement therapy for acute kidney injury. N Engl J Med 2012; 367:2505-2514.
73. Rewa O, Eurich E, Stelfox H, et al. Quality indicators in continuous renal replacement therapy (CRRT) care in critically ill patients: protocol for a systematic review. Syst Rev 2015; 4:102.